marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Esperion Therapeutics Balance Sheet 2011-2024 | ESPR
Annual Balance Sheet Esperion Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-77.7 M | -124 M | -207 M | -125 M | -165 M | -37 M | -33.4 M | -35.4 M | -73 M | -80.1 M | -56.5 M | 16.3 M | 5.33 M |
Long Term Debt |
3.02 M | 665 K | 524 K | 179 M | - | - | - | 1.02 M | 2.69 M | 4.3 M | - | 7.53 M | 6.9 M |
Long Term Debt Current |
1.55 M | 384 K | 1.39 M | 2.59 M | 454 K | - | 1.04 M | 1.71 M | 1.6 M | 638 K | - | - | - |
Total Non Current Liabilities |
- | - | - | 355 M | 128 M | - | - | 1.02 M | 2.69 M | 4.3 M | - | 7.53 M | 6.9 M |
Total Current Liabilities |
156 M | 92.3 M | 73.4 M | 94.1 M | 66.1 M | 64.3 M | 33.1 M | 15.6 M | 5.62 M | 5.49 M | 4.2 M | - | - |
Total Liabilities |
661 M | 572 M | 579 M | 449 M | 194 M | 64.3 M | 33.1 M | 16.6 M | 8.31 M | 9.79 M | 4.2 M | 24.7 M | 8.24 M |
Deferred Revenue |
25.4 M | 3.51 M | 5.68 M | 1.66 M | 2.15 M | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.55 B | -1.34 B | -1.11 B | -839 M | -695 M | -598 M | -396 M | -229 M | -154 M | -104 M | -68.1 M | -42 M | -30.2 M |
Total Assets |
206 M | 248 M | 382 M | 353 M | 214 M | 143 M | 278 M | 245 M | 296 M | 143 M | 78.3 M | 7.31 M | 2.18 M |
Cash and Cash Equivalents |
82.2 M | 125 M | 209 M | 305 M | 166 M | 37 M | 34.5 M | 38.2 M | 77.3 M | 85 M | 56.5 M | 6.51 M | 1.57 M |
Book Value |
-455 M | -324 M | -197 M | -96.1 M | 20 M | 79.1 M | 245 M | 229 M | 287 M | 134 M | 74.1 M | -17.4 M | -6.06 M |
Total Shareholders Equity |
-455 M | -324 M | -197 M | -96.1 M | 20 M | 79.1 M | 245 M | 229 M | 287 M | 134 M | 74.1 M | -41.4 M | -30 M |
All numbers in USD currency
Quarterly Balance Sheet Esperion Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
3.3 M | 3.98 M | 4.42 M | 2.05 M | 1.7 M | 782 K | 665 K | 47 K | - | 263 K | 524 K | 1.31 M | 1.92 M | 2.52 M | 3.45 M | 3.45 M | 3.45 M | 3.45 M | 1.11 M | 1.11 M | 1.11 M | 1.11 M | - | - | - | - | - | - | 140 K | 585 K | 1.02 M | 1.02 M | 1.02 M | 1.02 M | 2.69 M | 2.69 M | 2.69 M | 2.69 M | 4.23 M | 4.23 M | 4.23 M | 4.23 M | - | - | - | - | 7.53 M | 7.53 M | 7.53 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
684 M | 697 M | 667 M | 631 M | 607 M | 581 M | 572 M | 607 M | - | 592 M | 579 M | 588 M | 585 M | 548 M | 449 M | 449 M | 449 M | 449 M | 194 M | 194 M | 194 M | 194 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M | 33.1 M | 33.1 M | 33.1 M | 33.1 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 8.31 M | 8.31 M | 8.31 M | 8.31 M | 9.72 M | 9.72 M | 9.72 M | 9.72 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 24.7 M | 24.7 M | 24.7 M | - | - | - | - | - |
Deferred Revenue |
15.1 M | 20.7 M | 29.4 M | 19.7 M | 15.6 M | 12.2 M | 3.51 M | 4.04 M | - | 3.8 M | 5.68 M | 3.07 M | 3.93 M | 2.54 M | 1.66 M | 1.66 M | 1.66 M | 1.66 M | 2.15 M | 2.15 M | 2.15 M | 2.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-1.58 B | -1.55 B | -1.49 B | -1.49 B | -1.45 B | -1.4 B | -1.34 B | -1.28 B | - | -1.16 B | -1.11 B | -1.04 B | -972 M | -928 M | -839 M | -839 M | -839 M | -839 M | -695 M | -695 M | -695 M | -695 M | -598 M | -598 M | -598 M | -598 M | -396 M | -396 M | -396 M | -396 M | -229 M | -229 M | -229 M | -229 M | -154 M | -154 M | -154 M | -154 M | -104 M | -104 M | -104 M | -104 M | -68.1 M | -68.1 M | -68.1 M | - | - | - | - | - | - | - | - | - |
Total Assets |
314 M | 352 M | 373 M | 221 M | 235 M | 252 M | 248 M | 313 M | - | 343 M | 382 M | 225 M | 280 M | 279 M | 353 M | 353 M | 353 M | 353 M | 214 M | 214 M | 214 M | 214 M | 143 M | 143 M | 143 M | 143 M | 278 M | 278 M | 278 M | 278 M | 245 M | 245 M | 245 M | 245 M | 296 M | 296 M | 296 M | 296 M | 143 M | 143 M | 143 M | 143 M | 78.3 M | 78.3 M | 78.3 M | 78.3 M | 7.31 M | 7.31 M | 7.31 M | - | - | - | - | - |
Cash and Cash Equivalents |
145 M | 189 M | 227 M | 115 M | 138 M | 145 M | 125 M | 159 M | 123 M | 150 M | 209 M | 104 M | 219 M | 218 M | 305 M | 305 M | 305 M | 305 M | 166 M | 166 M | 166 M | 166 M | 37 M | 37 M | 37 M | 37 M | 34.5 M | 34.5 M | 34.5 M | 34.5 M | 38.2 M | 38.2 M | 38.2 M | 38.2 M | 77.3 M | 77.3 M | 77.3 M | 77.3 M | 85 M | 85 M | 85 M | 85 M | 56.5 M | 56.5 M | 56.5 M | 56.5 M | 6.51 M | 6.51 M | 6.51 M | - | 1.57 M | - | - | - |
Book Value |
-370 M | -344 M | -294 M | -410 M | -372 M | -330 M | -324 M | -294 M | - | -249 M | -197 M | -363 M | -304 M | -269 M | -96.1 M | -96.1 M | -96.1 M | -96.1 M | 20 M | 20 M | 20 M | 20 M | 79.1 M | 79.1 M | 79.1 M | 79.1 M | 245 M | 245 M | 245 M | 245 M | 229 M | 229 M | 229 M | 229 M | 287 M | 287 M | 287 M | 287 M | 134 M | 134 M | 134 M | 134 M | 74.1 M | 74.1 M | 74.1 M | 74.1 M | -17.4 M | -17.4 M | -17.4 M | - | - | - | - | - |
Total Shareholders Equity |
-370 M | -344 M | -294 M | -410 M | -372 M | -330 M | -324 M | -294 M | -292 M | -249 M | -197 M | -363 M | -304 M | -269 M | -96.1 M | -96.1 M | -96.1 M | -96.1 M | 20 M | 20 M | 20 M | 20 M | 79.1 M | 79.1 M | 79.1 M | 79.1 M | 245 M | 245 M | 245 M | 245 M | 229 M | 229 M | 229 M | 229 M | 287 M | 287 M | 287 M | 287 M | 134 M | 134 M | 134 M | 134 M | 74.1 M | 74.1 M | 74.1 M | 74.1 M | -41.4 M | -41.4 M | -41.4 M | - | -30 M | - | - | - |
All numbers in USD currency